Evaluating the tendencies of community practitioners who actively practice in child and adolescent psychiatry to diagnose and treat DSM-5 attenuated psychotic syndrome
- PMID: 34669043
- DOI: 10.1007/s00787-021-01897-1
Evaluating the tendencies of community practitioners who actively practice in child and adolescent psychiatry to diagnose and treat DSM-5 attenuated psychotic syndrome
Abstract
The detection of individuals at clinical ultra-high risk for psychosis (CHR-P) may be a key limiting step for early interventions, and there is some uncertainty regarding the true clinical reliability of the CHR-P states. The aim of this study was to explore how practitioners who were in the direct treatment of children with psychiatric disorders [child psychiatry specialists/trainees (n = 227, n = 131), adult psychiatrists (n = 27), and child neurologists (n = 2)] perceive the DSM-5-Attenuated Psychosis Syndrome (DSM-5-APS), and their clinical routine practice in the treatment of it. Three vignettes describing fictional cases presented with symptoms of either DSM-5-Schizophrenia, DSM-5-APS, and no psychotic symptoms were created. We asked these practitioners to apply a DSM-5 diagnosis and to choose appropriate treatment(s) for these vignettes. Of the responders, 43% correctly diagnosed the APS vignette, whereas 37.4% mentioned that it had a full-blown psychotic episode. Regarding the therapeutic approach for the APS vignette, 72.1% of all practitioners chose a psychopharmacological intervention and 32% individual psychotherapy. This study showed that the diagnostic inter-rater reliability of the DSM-5-APS among child/adolescent mental health practitioners was consistent with the results from the DSM-5 field trials (Kappa = 0.46). Moreover, almost three in four practitioners endorsed psychopharmacological intervention as a treatment option for the DSM-5-APS case. The lack of evidence of psychopharmacological interventions in CHR-P situations emphasizes that the least harmful interventions should be recommended. Thus, our findings indicated a need for raising awareness regarding the CHR-P paradigm and its treatment as well as the development of solid guidelines that can be implemented in clinical practice.
Keywords: Adolescence; Attenuated psychotic syndrome; Child psychiatry; Clinical high risk; Psychosis; Schizophrenia spectrum disorder.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Similar articles
-
Prognostic Accuracy of DSM-5 Attenuated Psychosis Syndrome in Adolescents: Prospective Real-World 5-Year Cohort Study.Schizophr Bull. 2021 Oct 21;47(6):1663-1673. doi: 10.1093/schbul/sbab041. Schizophr Bull. 2021. PMID: 33939829 Free PMC article.
-
Practitioner perceptions of attenuated psychosis syndrome.Schizophr Res. 2011 Sep;131(1-3):24-30. doi: 10.1016/j.schres.2011.06.022. Epub 2011 Jul 20. Schizophr Res. 2011. PMID: 21764261 Free PMC article.
-
[Attenuated psychosis syndrome: A new diagnostic category for further study in DSM-5].Psychiatriki. 2017 Apr-Jun;28(2):120-130. doi: 10.22365/jpsych.2017.282.120. Psychiatriki. 2017. PMID: 28686559 Greek, Modern.
-
[Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].Encephale. 2017 May;43(3):292-297. doi: 10.1016/j.encep.2017.01.005. Epub 2017 Mar 25. Encephale. 2017. PMID: 28347521 Review. French.
-
Attenuated psychosis syndrome in DSM-5.Schizophr Res. 2013 Oct;150(1):31-5. doi: 10.1016/j.schres.2013.05.004. Epub 2013 Jun 14. Schizophr Res. 2013. PMID: 23773295 Free PMC article. Review.
References
-
- Association AP (2013) Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub, Washington DC - DOI
-
- Bora E (2015) Neurodevelopmental origin of cognitive impairment in schizophrenia. Psychol Med 45:1–9. https://doi.org/10.1017/S0033291714001263 - DOI - PubMed
-
- Keefe RSE, Harvey PD (2012) Cognitive impairment in schizophrenia. In: Geyer MA, Gross G (eds) Novel antischizophrenia treatments. Springer Berlin Heidelberg, Berlin, Heidelberg, pp 11–37 - DOI
-
- van Os J, Kapur S (2009) Schizophrenia. Lancet 374:635–645. https://doi.org/10.1016/S0140-6736(09)60995-8 - DOI - PubMed
-
- Kafali HY, Bildik T, Bora E et al (2019) Distinguishing prodromal stage of bipolar disorder and early onset schizophrenia spectrum disorders during adolescence. Psychiatry Res 275:315–325 - DOI
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous